GILEAD SCIENCES, INC. Long-Term Concentrated

Location: Foster City, CA

CIK: 0000882095 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 12, 2026

Total Value: $1.936B (100.0% shares, 0.0% debt)

Holdings (6)

RCUS ARCUS BIOSCIENCES INC 38.7%

Value $749M Shares 31,424,760 Est. Cost $16.13 Unrealized +26.5%

GLPG GALAPAGOS NV 28.4%

Value $551M Shares 16,707,477 Est. Cost $27.64 Unrealized —

ACLX ARCELLX INC 22.6%

Value $438M Shares 6,720,803 Est. Cost $86.39 Unrealized -7.7%

ASMB ASSEMBLY BIOSCIENCES INC 7.9%

Value $153M Shares 4,505,391 Est. Cost $19.07 Unrealized +68.9%

KYTX KYVERNA THERAPEUTICS INC 2.0%

Value $38.79M Shares 4,126,119 Est. Cost $4.79 Unrealized +55.0%

XLO XILIO THERAPEUTICS INC 0.3%

Value $5.829M Shares 9,105,451 Est. Cost $0.98 Unrealized -23.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
RCUS	ARCUS BIOSCIENCES INC	31,424,760	$749M	38.7%	$16.13	+26.5%	COM	03969F109
GLPG	GALAPAGOS NV	16,707,477	$551M	28.4%	$27.64	—	SPON ADR	36315X101
ACLX	ARCELLX INC	6,720,803	$438M	22.6%	$86.39	-7.7%	COMMON STOCK	03940C100
ASMB	ASSEMBLY BIOSCIENCES INC	4,505,391	$153M	7.9%	$19.07	+68.9%	COM NEW	045396207
KYTX	KYVERNA THERAPEUTICS INC	4,126,119	$38.79M	2.0%	$4.79	+55.0%	COM	501976104
XLO	XILIO THERAPEUTICS INC	9,105,451	$5.829M	0.3%	$0.98	-23.6%	COM	98422T100